Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines
Viruses · 2024
DOI: 10.3390/v16101625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Scott A Gibson und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal, Diary and Veterinary Sciences, Utah State University, Logan, UT 84322, USA. Hauptthemen laut MEDLINE: COVID-19, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Contract number HHSN272201700041I, Task Order 75N93020F00001, Task A38, from the Virology Branch, DMID, NIAID, NIH, National Institute of Health.
Abstract (Originalsprache)
Animal models that are susceptible to SARS-CoV-2 infection and develop clinical signs like human COVID-19 are desired to understand viral pathogenesis and develop effective medical countermeasures. The golden Syrian hamster is important for the study of SARS-CoV-2 since hamsters are naturally susceptible to SARS-CoV-2. However, infected hamsters show only limited clinical disease and resolve infection quickly. In this study, we describe development of human angiotensin-converting enzyme 2 (hACE2) transgenic hamsters as a model for COVID-19. During development of the model for SARS-CoV-2, we observed that different hACE2 transgenic hamster founder lines varied in their susceptibility to SARS-CoV-2 lethal infection. The highly susceptible hACE2 founder lines F0F35 and F0M41 rapidly progress to severe infection and death within 6 days post-infection (p.i.). Clinical signs included lethargy, weight loss, dyspnea, and mortality. Lethality was observed in a viral dose-dependent manner with a lethal dose as low as 1 × 100.15 CCID50. In addition, virus shedding from highly susceptible lines was detected in oropharyngeal swabs on days 2–5 p.i., and virus titers were observed at 105.5−6.5 CCID50 in lung and brain tissue by day 4 p.i.. Histopathology revealed that infected hACE2-hamsters developed rhinitis, tracheitis, bronchointerstitial pneumonia, and encephalitis. Mortality in highly susceptible hACE2-hamsters can be attributed to neurologic disease with contributions from the accompanying respiratory disease. In contrast, virus challenge of animals from less susceptible founder lines, F0M44 and F0M51, resulted in only 0–20% mortality. To demonstrate utility of this SARS-CoV-2 infection model, we determined the protective effect of the TLR3 agonist polyinosinic-polycytidylic acid (Poly (I:C)). Prophylactic treatment with Poly (I:C) significantly improved survival in highly susceptible hACE2-hamsters. In summary, our studies demonstrate that hACE2 transgenic hamsters differ in their susceptibility to SARS-CoV-2 infection, based on the transgenic hamster founder line, and that prophylactic treatment with Poly (I:C) was protective in this COVID-19 model of highly susceptible hACE2-hamsters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal, Diary and Veterinary Sciences, Utah State University, Logan, UT 84322, USA.
- Institute for Antiviral Research, Utah State University, Logan, UT 84322, USA.
- Department of Veterinary, Clinical, and Life Sciences, Utah State University, Logan, UT 84322, USA.
- Utah Veterinary Diagnostic Laboratory, Utah State University, Logan, UT 84322, USA.
- Institute of Biogenesis Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96822, USA.
ORCID-Profile: Brett L Hurst, Irina A Polejaeva, Arnaud J Van Wettere, Stefan Moisyadi, E Bart Tarbet, Zhongde Wang
Förderung
- NIAID NIH HHS
- Contract number HHSN272201700041I, Task Order 75N93020F00001, Task A38, from the Virology Branch, DMID, NIAID, NIH
- National Institute of Health
Zitieren
APA
Gibson, S. A., Liu, Y., Li, R., Hurst, B. L., Fan, Z., Siddharthan, V., Larson, D. P., Sheesley, A. Y., Stewart, R., Kunzler, M., Polejaeva, I. A., Van Wettere, A. J., Moisyadi, S., Morrey, J. D., Tarbet, E. B., & Wang, Z. (2024). Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines. Viruses. https://doi.org/10.3390/v16101625
Vancouver
Gibson SA, Liu Y, Li R, Hurst BL, Fan Z, Siddharthan V, et al. Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines. Viruses. 2024. doi:10.3390/v16101625
BibTeX
@article{Gibson2024,
author = {Gibson, Scott A and Liu, Yanan and Li, Rong and Hurst, Brett L and Fan, Zhiqiang and Siddharthan, Venkatraman and Larson, Deanna P and Sheesley, Ashley Y and Stewart, Rebekah and Kunzler, Madelyn and Polejaeva, Irina A and Van Wettere, Arnaud J and Moisyadi, Stefan and Morrey, John D and Tarbet, E Bart and Wang, Zhongde},
title = {Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16101625}
}
EUVIMED